Filing Details

Accession Number:
0001415889-24-020461
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-31 17:15:05
Reporting Period:
2024-07-29
Accepted Time:
2024-07-31 17:15:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA Pharmaceutical Preparations (2834) 300409740
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831410 Cyrus Harmon C/O Olema Pharmaceuticals, Inc.
780 Brannan St
San Francisco CA 94103
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-29 4,066 $15.58 752,217 No 4 S Direct
Common Stock Disposition 2024-07-30 934 $15.55 751,283 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 122,028 Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated May 16, 2023.
  2. The weighted average sale price for the transaction reported was $15.58, and the range of prices was between $15.55 and $15.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. The weighted average sale price for the transaction reported was $15.55, and the range of prices was between $15.55 and $15.58. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
  4. The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.